Cargando…

Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery

We realized a narrative review of the current literature starting from the case of a patient with raised CA15-3 during an uncomplicated pregnancy after breast cancer. The aim of our paper was to assess specificity, physiological changes and clinical utility of CA 15-3 monitoring during pregnancy aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Buonomo, Barbara, Noli, Stefania A, Santini, Alessandra, Alviggi, Carlo, Peccatori, Fedro A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946420/
https://www.ncbi.nlm.nih.gov/pubmed/31921350
http://dx.doi.org/10.3332/ecancer.2019.979
_version_ 1783485358791458816
author Buonomo, Barbara
Noli, Stefania A
Santini, Alessandra
Alviggi, Carlo
Peccatori, Fedro A
author_facet Buonomo, Barbara
Noli, Stefania A
Santini, Alessandra
Alviggi, Carlo
Peccatori, Fedro A
author_sort Buonomo, Barbara
collection PubMed
description We realized a narrative review of the current literature starting from the case of a patient with raised CA15-3 during an uncomplicated pregnancy after breast cancer. The aim of our paper was to assess specificity, physiological changes and clinical utility of CA 15-3 monitoring during pregnancy after breast cancer, starting from clinical practice and retrieving the most relevant evidence in the literature.
format Online
Article
Text
id pubmed-6946420
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-69464202020-01-09 Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery Buonomo, Barbara Noli, Stefania A Santini, Alessandra Alviggi, Carlo Peccatori, Fedro A Ecancermedicalscience Case Report We realized a narrative review of the current literature starting from the case of a patient with raised CA15-3 during an uncomplicated pregnancy after breast cancer. The aim of our paper was to assess specificity, physiological changes and clinical utility of CA 15-3 monitoring during pregnancy after breast cancer, starting from clinical practice and retrieving the most relevant evidence in the literature. Cancer Intelligence 2019-11-26 /pmc/articles/PMC6946420/ /pubmed/31921350 http://dx.doi.org/10.3332/ecancer.2019.979 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Buonomo, Barbara
Noli, Stefania A
Santini, Alessandra
Alviggi, Carlo
Peccatori, Fedro A
Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery
title Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery
title_full Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery
title_fullStr Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery
title_full_unstemmed Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery
title_short Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery
title_sort can we trust tumour markers in pregnancy after breast cancer? a case of elevated ca 15-3 in the third trimester of pregnancy normalising after delivery
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946420/
https://www.ncbi.nlm.nih.gov/pubmed/31921350
http://dx.doi.org/10.3332/ecancer.2019.979
work_keys_str_mv AT buonomobarbara canwetrusttumourmarkersinpregnancyafterbreastcanceracaseofelevatedca153inthethirdtrimesterofpregnancynormalisingafterdelivery
AT nolistefaniaa canwetrusttumourmarkersinpregnancyafterbreastcanceracaseofelevatedca153inthethirdtrimesterofpregnancynormalisingafterdelivery
AT santinialessandra canwetrusttumourmarkersinpregnancyafterbreastcanceracaseofelevatedca153inthethirdtrimesterofpregnancynormalisingafterdelivery
AT alviggicarlo canwetrusttumourmarkersinpregnancyafterbreastcanceracaseofelevatedca153inthethirdtrimesterofpregnancynormalisingafterdelivery
AT peccatorifedroa canwetrusttumourmarkersinpregnancyafterbreastcanceracaseofelevatedca153inthethirdtrimesterofpregnancynormalisingafterdelivery